s a
growth-stage medical device company pioneering silk-based biomaterial
platforms for tissue regeneration. Incorporated in 1998, Serica's proprietary
products currently in preclinical and clinical development are being studied
in the areas of orthopaedic and sports medicine, aesthetic and reconstructive
plastic surgery and other structural tissue repair needs, and drug delivery
applications. Serica's team of engineers and scientists are located in a
state-of-the-art 26,000-square-foot office, R&D and manufacturing facility in
Medford, MA. For more information about Serica Technologies, please visit
www.sericainc.com.
About Morningside Technology Ventures
Morningside is a diversified investment group founded in 1986 by the Chan
family which is the controlling shareholder of the Hang Lung Group in Hong
Kong. Morningside is engaged in both private equity and venture capital
investments in North America, Europe and across Asia Pacific. In recent years,
leveraging on its experience investing in biotechnology companies in North
America, Morningside has become the leading investor in the life science
sector in China. For more information, visit www.morningside.com.
About Prism VentureWorks
Founded in 1996, Prism VentureWorks (Westwood, MA, Santa Monica, CA) is a
venture capital firm built by experienced entrepreneurs in technology and life
sciences. With approximately $1.25 billion in capital under management across
five funds, Prism's primary goal is to deliver superior value to its
investors. Its partners have served as the founders, CEOs and senior
executives of numerous venture-backed companies. By leveraging its network of
seasoned entrepreneurs, skilled executives and long-time industry contacts,
Prism identifies and works closely with companies with the potential to be
mar
'/>"/>
SOURCE Serica Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing2.
Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering3.
Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction4.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results5.
BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery6.
Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators7.
China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day8.
Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth9.
Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership10.
Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel11.
Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices